SCHEMBL23856884

SCHEMBL23856884

O=C1NCC(C2CCN(C(=O)O)CC2)O1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
CCRL2 O00421 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23871932 0.79 GPR119 (0.53)
SCHEMBL25216966 0.77
SCHEMBL19211581 0.75 CHRNB2 (0.32)
SCHEMBL19211588 0.75 CHRNB2 (0.32)
SCHEMBL19211575 0.75 CHRNB2 (0.32)
SCHEMBL10242155 0.73 MAPT (0.34)
SCHEMBL25233923 0.72 DAO (0.34)
SCHEMBL1936310 0.70 HSD11B1 (0.37)
SCHEMBL17112985 0.68 SMYD3 (0.30)
SCHEMBL19212832 0.68 SMYD3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126855-B1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS HOFFMANN LA ROCHE (CH) 2024-04-24 EP disclosed
EP-4126855-A1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2023-02-08 EP disclosed
WO-2021190727-A1 COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2021-09-30 WO disclosed